These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21072364)

  • 1. The hazards of iron loading.
    Weinberg ED
    Metallomics; 2010 Nov; 2(11):732-40. PubMed ID: 21072364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of iron chelators in diseases associated with iron mismanagement.
    Weinberg ED
    J Pharm Pharmacol; 2006 May; 58(5):575-84. PubMed ID: 16640825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is addition of iron to processed foods safe for iron replete consumers?
    Weinberg ED
    Med Hypotheses; 2009 Dec; 73(6):948-9. PubMed ID: 19628337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron out-of-balance: a risk factor for acute and chronic diseases.
    Weinberg ED
    Hemoglobin; 2008; 32(1-2):117-22. PubMed ID: 18274989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload and toxicity: the hidden risk of multiple blood transfusions.
    Shander A; Cappellini MD; Goodnough LT
    Vox Sang; 2009 Oct; 97(3):185-97. PubMed ID: 19663936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of phlebotomy with a low iron diet in the management of pulmonary iron overload].
    Fukuda T; Kimura F; Watanabe Y; Yoshino T; Kimura I
    Rinsho Ketsueki; 2003 May; 44(5):323-7. PubMed ID: 12822407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic iron overload and toxicity: clinical chemistry perspective.
    Kang JO
    Clin Lab Sci; 2001; 14(3):209-19; quiz 222. PubMed ID: 11517632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron loading and disease surveillance.
    Weinberg ED
    Emerg Infect Dis; 1999; 5(3):346-52. PubMed ID: 10341171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering body iron stores in the prevention of type 2 diabetes.
    Mascitelli L; Pezzetta F
    Intern Med J; 2006 Oct; 36(10):685-6. PubMed ID: 16958654
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases.
    Kontoghiorghes GJ; Kolnagou A; Peng CT; Shah SV; Aessopos A
    Expert Opin Drug Saf; 2010 Mar; 9(2):201-6. PubMed ID: 20059374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron metabolism and toxicity.
    Papanikolaou G; Pantopoulos K
    Toxicol Appl Pharmacol; 2005 Jan; 202(2):199-211. PubMed ID: 15629195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron withholding: a defense against disease.
    Weinberg ED; Miklossy J
    J Alzheimers Dis; 2008 May; 13(4):451-63. PubMed ID: 18487852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary iron overload in the African and hepatocellular carcinoma.
    Kew MC; Asare GA
    Liver Int; 2007 Aug; 27(6):735-41. PubMed ID: 17617115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron toxicity: new conditions continue to emerge.
    Weinberg ED
    Oxid Med Cell Longev; 2009; 2(2):107-9. PubMed ID: 20357933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload in the erythropoietin era.
    Robbins KC
    Nephrol Nurs J; 2000 Apr; 27(2):227-31. PubMed ID: 11111550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
    Zecca L; Casella L; Albertini A; Bellei C; Zucca FA; Engelen M; Zadlo A; Szewczyk G; Zareba M; Sarna T
    J Neurochem; 2008 Aug; 106(4):1866-75. PubMed ID: 18624918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of iron loading and toxicity.
    Anderson GJ
    Am J Hematol; 2007 Dec; 82(12 Suppl):1128-31. PubMed ID: 17963252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron and the liver.
    Corradini E; Ferrara F; Pietrangelo A
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():245-8. PubMed ID: 16462704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron: tolerable upper intake levels.
    Nutr Clin Care; 2002; 5(5):236-50. PubMed ID: 12455226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebselen decreases oxygen free radical production and iron concentrations in the hearts of chronically iron-overloaded mice.
    Davis MT; Bartfay WJ
    Biol Res Nurs; 2004 Jul; 6(1):37-45. PubMed ID: 15186706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.